 | • レポートコード：TPM-BG059 • 出版社/出版日：Transparency Market Research / 2018年6月 • レポート形態：英文、PDF、336ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、イムノアッセイの世界市場について調べ、イムノアッセイの世界規模、市場動向、市場環境、技術別（化学ルミネセンス免疫検定(CLIA)、酵素結合免疫吸着測定法（ELISA）、酵素免疫蛍光法（ELFA）.ラジオイムノアッセイ（RIA））分析、製品別（アナライザ、消耗品）分析、用途別（感染症、内分泌学、腫瘍学、心臓学、整形外科）分析、最終用途別（病院・診断研究所、血液バンク）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・イムノアッセイの世界市場動向 ・イムノアッセイの世界市場環境 ・イムノアッセイの世界市場規模 ・イムノアッセイの世界市場規模：技術別（化学ルミネセンス免疫検定(CLIA)、酵素結合免疫吸着測定法（ELISA）、酵素免疫蛍光法（ELFA）.ラジオイムノアッセイ（RIA）） ・イムノアッセイの世界市場規模：製品別（アナライザ、消耗品） ・イムノアッセイの世界市場規模：用途別（感染症、内分泌学、腫瘍学、心臓学、整形外科） ・イムノアッセイの世界市場規模：最終用途別（病院・診断研究所、血液バンク） ・イムノアッセイの世界市場：地域別市場規模・分析 ・イムノアッセイの北米市場規模・予測 ・イムノアッセイのアメリカ市場規模・予測 ・イムノアッセイの中南米市場規模・予測 ・イムノアッセイのヨーロッパ市場規模・予測 ・イムノアッセイのアジア市場規模・予測 ・イムノアッセイの日本市場規模・予測 ・イムノアッセイの中国市場規模・予測 ・イムノアッセイのインド市場規模・予測 ・イムノアッセイの中東市場規模・予測 ・イムノアッセイのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Immunoassay Market – Overview
This report on the immunoassay market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in manufacturing, commercializing, and providing immunoassays and new entrants planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments considered in the scope of the study. This section also provides the overall information and data analysis of the global immunoassay market regarding leading market segments based on technology, product, application, end-user, and region.
The global immunoassay market has been classified based on technology, product, application, end-user, and region. Based on product, the global market has been segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunoassay (ELISA), enzyme-linked immunofluorescent assay (ELFA), radioimmunoassay (RIA), and others. In terms of product, the market has been categorized into analyzer and consumables. Based on application, the global immunoassay market has been divided into infectious disease, endocrinology, oncology, cardiology, orthopedics, and others. In terms of end-user, the market has been segmented into hospitals and diagnostics laboratories, blood banks, and others.
Each of the market segments have been extensively divided based on market-related factors such as rise in incidence rate and prevalence of acute, chronic, and infectious diseases; technological advancements in health care diagnostics; and emerging trends in the health care, pharmaceutical, and biotechnology industries. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.
The market overview section of the report explores market dynamics such as drivers, restraints, opportunities, and key trends that have a strong impact on the immunoassay market and could influence it in the near future. Market attractiveness analysis has been provided in an overview section to explain the intensity of competition in the market across different regions. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. These factors are likely to help market players take strategic decisions to strengthen their positions and expand their shares in the global immunoassay market.
Based on region, the immunoassay market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides market size and forecast for major countries with each product and end-user in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides the market attractiveness analysis and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global immunoassay market.
Major players operating in the global Immunoassay market are F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories, Siemens Healthineers (Siemens AG), Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Ortho Clinical Diagnostics (a part of Carlyle Group), bioMérieux SA, Sysmex Corporation, and DiaSorin S.p.A..
The global Immunoassay market is segmented as follows:
Global Immunoassay Market Revenue, by Technology
Chemiluminescence Immunoassay (CLIA)
Enzyme-linked Immunoassay (ELISA)
Enzyme-linked Immunofluorescent Assay (ELFA)
Radioimmunoassay (RIA)
Others
Global Immunoassay Market Revenue, by Product
Analyzer
Consumables
Global Immunoassay Market Revenue, by Application
Infectious Disease
Endocrinology
Oncology
Cardiology
Orthopedics
Others
Global Immunoassay Market Revenue, by End-user
Hospitals and Diagnostics Laboratories
Blood Banks
Others
Global Immunoassay Market Revenue, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of Latin America
Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of Middle East & Africa
Chapter 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary: Global Immunoassay Market
Chapter 4 Market Overview
4.1. Introduction
4.2. Key Industry Developments
Chapter 5 Market Dynamics
5.1. Drivers
5.2. Restraints
5.3. Opportunities
5.4. Key Trends
5.5. Global Immunoassay Market Size (US$ Mn) Forecast, 2016–2026
5.6. Global Immunoassay Market Outlook
5.7. Industry Mergers & Acquisitions
5.8. Automate Immunoassay Analyzer Volume
5.9. Distributor Analysis
5.10. Regulatory Assessments, by Key Country/Region
5.11. Winning Imperatives
Chapter 6 Global Immunoassay Market Analysis and Forecast, by Technology
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
6.3.1. Chemiluminescence Immunoassay (CLIA)
6.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
6.3.3. Enzyme-linked Fluorescent Assay (ELFA)
6.3.4. Radioimmunoassay (RIA)
6.3.5. Others ( Microarray, Immunofluorescence Assay Biochip Assay, Counting Immunoassay)
6.4. Market Attractiveness Analysis, by Technology
Chapter 7 Global Immunoassay Market Analysis and Forecast, by Product
7.1. Key Findings
7.2. Introduction
7.3. Market Size (US$ Mn) Forecast, by Product, 2018–2026
7.3.1. Analyzer
7.3.2. Consumables
7.4. Market Attractiveness Analysis, by Product
Chapter 8 Global Immunoassay Market Analysis and Forecast, by Application
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast, by Application, 2018–2026
8.3.1. Infectious Disease
8.3.2. Endocrinology
8.3.3. Oncology
8.3.4. Cardiology
8.3.5. Orthopedics
8.3.6. Others (Autoimmune Disorders, Allergy, Therapeutic Drug Monitoring, Liver Diseases, Acid Base Tests, GI Stool Testing, etc.)
8.4. Market Attractiveness Analysis, by Application
Chapter 9 Global Immunoassay Market Analysis and Forecasts, by End-user
9.1. Key Findings
9.2. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
9.2.1. Hospitals and Diagnostics Laboratories
9.2.2. Blood Banks
9.2.3. Others (Academic & Research Institutes, Pharmaceutical & Biotech Companies)
9.3. Market Attractiveness Analysis, by End-user
Chapter 10 Global Immunoassay Market Analysis and Forecasts, by Region
10.1. Key Findings
10.2. Global Market Scenario
10.3. Market Value (US$ Mn) Forecast, by Region, 2018–2026
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
10.4. Market Attractiveness Analysis, by Region
10.5. Key Trends, by Region
Chapter 11 North America Immunoassay Market Analysis and Forecast
11.1. Market Overview
11.2. Market Size (US$ Mn) Forecast, by Country, 2018–2026
11.2.1. U.S.
11.2.2. Canada
11.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
11.3.1. Chemiluminescence Immunoassay (CLIA)
11.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
11.3.3. Enzyme Linked Fluorescent Assay (ELFA)
11.3.4. Radioimmunoassay (RIA)
11.3.5. Others
11.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
11.4.1. Analyzers
11.4.2. Consumables
11.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
11.5.1. Infectious Disease
11.5.2. Endocrinology
11.5.3. Oncology
11.5.4. Cardiology
11.5.5. Orthopedics
11.5.6. Others
11.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
11.6.1. Hospitals and Diagnostics Laboratories
11.6.2. Blood Banks
11.6.3. Others
11.7. Market Attractiveness Analysis
11.7.1. By Country
11.7.2. By Technology
11.7.3. By Product
11.7.4. By Application
11.7.5. By End-user
Chapter 12 Europe Immunoassay market Analysis and Forecast
12.1. Market Overview
12.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
12.2.1. U.K.
12.2.2. Germany
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Rest of Europe
12.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
12.3.1. Chemiluminescence Immunoassay (CLIA)
12.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
12.3.3. Enzyme Linked Fluorescent Assay (ELFA)
12.3.4. Radioimmunoassay (RIA)
12.3.5. Others
12.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
12.4.1. Analyzers
12.4.2. Consumables
12.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
12.5.1. Infectious Disease
12.5.2. Endocrinology
12.5.3. Oncology
12.5.4. Cardiology
12.5.5. Orthopedics
12.5.6. Others
12.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
12.6.1. Hospitals and Diagnostics Laboratories
12.6.2. Blood Banks
12.6.3. Others
12.7. Market Attractiveness Analysis
12.7.1. By Country
12.7.2. By Technology
12.7.3. By Product
12.7.4. By Application
12.7.5. By End-user
Chapter 13 Asia Pacific Immunoassay Market Analysis and Forecast
13.1. Market Overview
13.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
13.2.1. China
13.2.2. India
13.2.3. Japan
13.2.4. Australia & New Zealand
13.2.5. Rest of Asia Pacific
13.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
13.3.1. Chemiluminescence Immunoassay (CLIA)
13.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
13.3.3. Enzyme Linked Fluorescent Assay (ELFA)
13.3.4. Radioimmunoassay (RIA)
13.3.5. Others
13.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
13.4.1. Analyzers
13.4.2. Consumables
13.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
13.5.1. Infectious Disease
13.5.2. Endocrinology
13.5.3. Oncology
13.5.4. Cardiology
13.5.5. Orthopedics
13.5.6. Others
13.6. Market size (US$ Mn) Forecast, by End-user, 2018–2026
13.6.1. Hospitals and Diagnostics Laboratories
13.6.2. Blood Banks
13.6.3. Others
13.7. Market Attractiveness Analysis
13.7.1. By Country
13.7.2. By Technology
13.7.3. By Product
13.7.4. By Application
13.7.5. By End-user
Chapter 14 Latin America Immunoassay Market Analysis and Forecast
14.1. Market Overview
14.2. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
14.2.1. Brazil
14.2.2. Mexico
14.2.3. Rest of Latin America
14.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
14.3.1. Chemiluminescence Immunoassay (CLIA)
14.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
14.3.3. Enzyme Linked Fluorescent Assay (ELFA)
14.3.4. Radioimmunoassay (RIA)
14.3.5. Others
14.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
14.4.1. Analyzers
14.4.2. Consumables
14.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
14.5.1. Infectious Disease
14.5.2. Endocrinology
14.5.3. Oncology
14.5.4. Cardiology
14.5.5. Orthopedics
14.5.6. Others
14.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
14.6.1. Hospitals and Diagnostics Laboratories
14.6.2. Blood Banks
14.6.3. Others
14.7. Market Attractiveness Analysis
14.7.1. By Country
14.7.2. By Technology
14.7.3. By Product
14.7.4. By Application
14.7.5. By End-user
Chapter 15 Middle East and Africa Immunoassay Market Analysis and Forecast
15.1. Market Overview
15.2. Market size (US$ Mn) Forecast, by Country/Sub-region, 2018–2026
15.2.1. GCC Countries
15.2.2. South Africa
15.2.3. Rest of Middle East and Africa
15.3. Market Size (US$ Mn) Forecast, by Technology, 2018–2026
15.3.1. Chemiluminescence Immunoassay (CLIA)
15.3.2. Enzyme-linked Immunosorbent Assay (ELISA)
15.3.3. Enzyme Linked Fluorescent Assay (ELFA)
15.3.4. Radioimmunoassay (RIA)
15.3.5. Others
15.4. Market Size (US$ Mn) Forecast, by Product, 2018–2026
15.4.1. Analyzers
15.4.2. Consumables
15.5. Market Size (US$ Mn) Forecast, by Application, 2018–2026
15.5.1. Infectious Disease
15.5.2. Endocrinology
15.5.3. Oncology
15.5.4. Cardiology
15.5.5. Orthopedics
15.5.6. Others
15.6. Market Size (US$ Mn) Forecast, by End-user, 2018–2026
15.6.1. Hospitals and Diagnostics Laboratories
15.6.2. Blood Banks
15.6.3. Others
15.7. Market Attractiveness Analysis
15.7.1. By Country
15.7.2. By Technology
15.7.3. By Product
15.7.4. By Application
15.7.5. By End-user
Chapter 16 Competition Landscape
16.1. Global Immunoassay Market Share, by Company, 2017
16.2. Market Player – Competition Matrix (By Tier and Size of Companies)
16.3. Company Profiles
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Financial Overview
16.3.1.5. Strategic Overview
16.3.2. Danaher Corporation.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Financial Overview
16.3.2.5. Strategic Overview
16.3.3. Abbott Laboratories.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Financial Overview
16.3.3.5. Strategic Overview
16.3.4. Siemens Healthineers (Siemens AG)
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Financial Overview
16.3.4.5. Strategic Overview
16.3.5. DiaSorin S.p.A.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Financial Overview
16.3.5.5. Strategic Overview
16.3.6. Sysmex Corporation.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Financial Overview
16.3.6.5. Strategic Overview
16.3.7. bioMérieux SA
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Financial Overview
16.3.7.5. Strategic Overview
16.3.8. Ortho Clinical Diagnostics (a part of Carlyle Group).
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Financial Overview
16.3.8.5. Strategic Overview
16.3.9. Thermo Fisher Scientific, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Financial Overview
16.3.9.5. Strategic Overview
16.3.10. Becton, Dickinson and Company.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Financial Overview
16.3.10.5. Strategic Overview
16.3.11. Merck KGaA.
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Financial Overview
16.3.11.5. Strategic Overview
Table 01: Global Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 02: Global Immunoassay Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 03: Global Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 04: Global Immunoassay Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Immunoassay Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Immunoassay Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 08: North America Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 09: North America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 10: North America Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: U.S. Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 12: U.S. Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 13: U.S. Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 14: U.S. Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Canada Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 16: Canada Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 17: Canada Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Canada Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 19: Europe Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Europe Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 21: Europe Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Europe Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 23: Europe Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Germany Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 25: Germany Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 26: Germany Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 27: Germany Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 28: U.K. Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 29: U.K. Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 30: U.K. Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 31: U.K. Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: France Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 33: France Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 34: France Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 35: France Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 36: Italy Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 37: Italy Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 38: Italy Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 39: Italy Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 40: Spain Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 41: Spain Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 42: Spain Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 43: Spain Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 44: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 45: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 46: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 47: Asia Pacific Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 48: Asia Pacific Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 49: China Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 50: China Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 51: China Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 52: China Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 53: India Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 54: India Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 55: India Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 56: India Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 57: Japan Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 58: Japan Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 59: Japan Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 60: Japan Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 61: Australia & New Zealand Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 62: Australia & New Zealand Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 63: Australia & New Zealand Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 64: Australia & New Zealand Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 65: Latin America Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 66: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 67: Latin America Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 68: Latin America Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 69: Latin America Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 70: Brazil Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 71: Brazil Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 72: Brazil Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 73: Brazil Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 74: Mexico Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 75: Mexico Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 76: Mexico Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 77: Mexico Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 78: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 79: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 80: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 81: Middle East & Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 82: Middle East & Africa Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 83: GCC Countries Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 84: GCC Countries Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 85: GCC Countries Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 86: GCC Countries Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 87: South Africa Immunoassay Market Size (US$ Mn) Forecast, by Technology, 2016–2026
Table 88: South Africa Immunoassay Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 89: South Africa Immunoassay Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 90: South Africa Immunoassay Market Value (US$ Mn) Forecast, by End-user, 2016–2026